Keyphrases
Acetate Buffer
25%
Additional Needs
20%
Affinity Labeling
25%
Angiotensin Receptor Blockers
40%
Angiotensin Receptor-neprilysin Inhibitor
20%
Angiotensin-converting Enzyme Inhibitor (ACEi)
20%
Application Usage
25%
Association Constant
25%
Binding Interaction
25%
Buffer pH
25%
Capillary Method
25%
Cardiology Clinic
20%
Cluster Anions
25%
Colorimetric Immunoassay
100%
Copper Cluster
100%
D-penicillamine
25%
Downscaling
25%
Elution Rate
25%
Emergency Department Services
20%
English Speaking
20%
Guideline-directed Medical Therapy
100%
Heart Disease Diagnosis
20%
Heart Failure
100%
Heart Failure with Preserved Ejection Fraction (HFpEF)
60%
Immunoaffinity Assays
25%
Inpatient Services
20%
Labeling Method
100%
Lysine
100%
Medical Patients
20%
Medicines Optimisation
100%
Molecular Weight Range
25%
Neutral pH
25%
New-onset Heart Failure
20%
Non-biological
25%
Oklahoma
60%
Optimal Dose
60%
Patient Education
20%
Patients with Heart Failure
20%
Pharmacist Perspectives
100%
Pharmacist-led Services
20%
Retrospective Chart Review
20%
Sensitivity Threshold
25%
Spectrophotometric Method
25%
Spironolactone
20%
State Universities
60%
Therapy Initiation
20%
Titration
20%
University Medical Centre
60%
Violet
25%
Zone Electrophoresis
25%
Medicine and Dentistry
ACE Inhibitor
20%
Aldosterone Antagonist
20%
Angiotensin Receptor Antagonist
40%
Beta Adrenergic Receptor Blocking Agent
20%
Cardiology
20%
Combination Therapy
100%
Congestive Heart Failure
100%
Drug Therapy
100%
Echocardiography
20%
Emergency Department
20%
Enkephalinase Inhibitor
20%
Heart Failure with Reduced Ejection Fraction
60%
Optimal Drug Dose
60%
Quality Improvement
20%
Spironolactone
20%
Titrimetry
20%
Pharmacology, Toxicology and Pharmaceutical Science
Aldosterone Antagonist
20%
Angiotensin Receptor Antagonist
40%
Beta Adrenergic Receptor Blocking Agent
20%
Combination Therapy
100%
Congestive Heart Failure
100%
Dipeptidyl Carboxypeptidase Inhibitor
20%
Enkephalinase Inhibitor
20%
Heart Failure with Reduced Ejection Fraction
60%
Spironolactone
20%